Abstract
We describe a 68-year-old patient with Parkinson's disease who developed retroperitoneal fibrosis during pergolide treatment. Because pergolide is an ergot derivative, it could be related to the development of this complication.
MeSH terms
-
Aged
-
Antiparkinson Agents / adverse effects*
-
Antiparkinson Agents / therapeutic use*
-
Dopamine Agonists / adverse effects*
-
Dopamine Agonists / therapeutic use*
-
Female
-
Humans
-
Parkinson Disease / complications
-
Parkinson Disease / drug therapy*
-
Pergolide / adverse effects*
-
Pergolide / therapeutic use*
-
Retroperitoneal Fibrosis / chemically induced*
-
Retroperitoneal Fibrosis / complications
Substances
-
Antiparkinson Agents
-
Dopamine Agonists
-
Pergolide